Skip to Main Content

Paper Details

Enrichment of Targetable Mutations in the Relapsed Neuroblastoma Genome.
PLoS Genet
84
2016
ALK, ALK mutations, MAPK, Neuroblastoma, Patients, RAS, Relapsed Neuroblastoma Genome, cancer, cancer gene panel, mutation-carrying cells, neuroblastoma, neuroblastoma tumor, neuroblastomas, patient, patients, tumor, tumors
Author NameAffiliation
Pichai RamanChildren's Hospital of Philadelphia and the University of Pennsylvania
Pichai RamanChildren's Hospital of Philadelphia and the University of Pennsylvania
Karthik KalletlaChildren's Hospital of Philadelphia and the University of Pennsylvania
Siraj M AliFoundation Medicine, Inc.
Vincent A MillerFoundation Medicine, Inc.
Yael P MosseChildren's Hospital of Philadelphia and the University of Pennsylvania
John M MarisChildren's Hospital of Philadelphia and the University of Pennsylvania
John M MarisChildren's Hospital of Philadelphia and the University of Pennsylvania
  • 1 - 8

Datasets

Release 1.2